NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 110 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $850,140 | -61.7% | 794,523 | -7.2% | 0.00% | – |
Q2 2023 | $2,218,506 | -26.5% | 856,566 | +15.9% | 0.00% | – |
Q1 2023 | $3,016,556 | -57.4% | 739,352 | -47.5% | 0.00% | – |
Q4 2022 | $7,073,692 | -36.8% | 1,409,102 | +64.7% | 0.00% | -100.0% |
Q3 2022 | $11,191,000 | +13.3% | 855,575 | +11.0% | 0.00% | 0.0% |
Q2 2022 | $9,877,000 | -6.3% | 770,442 | +11.4% | 0.00% | 0.0% |
Q1 2022 | $10,545,000 | -11.8% | 691,506 | +2.4% | 0.00% | 0.0% |
Q4 2021 | $11,961,000 | -8.4% | 675,380 | +8.7% | 0.00% | 0.0% |
Q3 2021 | $13,057,000 | +11.4% | 621,163 | +4.5% | 0.00% | 0.0% |
Q2 2021 | $11,726,000 | -17.3% | 594,618 | +21.9% | 0.00% | 0.0% |
Q1 2021 | $14,177,000 | +0.6% | 487,682 | +4.8% | 0.00% | 0.0% |
Q4 2020 | $14,093,000 | +100.6% | 465,203 | +5.3% | 0.00% | – |
Q3 2020 | $7,027,000 | -23.4% | 441,700 | -4.9% | 0.00% | -100.0% |
Q2 2020 | $9,172,000 | +62.0% | 464,626 | +1.2% | 0.00% | – |
Q1 2020 | $5,660,000 | -18.7% | 459,052 | +21.9% | 0.00% | – |
Q4 2019 | $6,965,000 | +287.4% | 376,673 | +190.2% | 0.00% | – |
Q3 2019 | $1,798,000 | +145.6% | 129,820 | +45.7% | 0.00% | – |
Q2 2019 | $732,000 | – | 89,095 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |